Pharmaceuticals Brazil

Brazil PTSD Treatment Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Brazil PTSD Treatment Market Industry Trends and Forecast to 2034: Segmented by (Treatment, Population, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Brazil · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $41.0 Mn Placeholder estimate
Estimate 2025 $43.9 Mn 2.6% of the global market
Projected 2034 $82.1 Mn 87% Adds $38.2 Mn over 9 forecast years
CAGR 2025–2034 7.2% Faster than 27% of 180 Pharmaceuticals markets here
Key players 5
  • Brazil is 2.6% of the global market.
  • In Latin America, the largest is Brazil (this report) at $43.9 Mn.
  • Fastest growing: Brazil (this report) at 7.2% a year.
  • Brazil ranks 1st of 3 by size in Latin America.

Market size projection

Brazil

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$38.2 Mn total, 2026–2034

Year-by-year market size, 2024–2034
PTSD Treatment Market market size by year, Brazil
YearMarket sizeChange that yearSince 2025
2024 (estimate) $41.0 Mn — —
2025 (base) $43.9 Mn +$2.9 Mn —
2026 (forecast) $47.1 Mn +$3.2 Mn +7.2%
2027 (forecast) $50.4 Mn +$3.4 Mn +14.9%
2028 (forecast) $54.1 Mn +$3.6 Mn +23.2%
2029 (forecast) $58.0 Mn +$3.9 Mn +32.1%
2030 (forecast) $62.1 Mn +$4.2 Mn +41.6%
2031 (forecast) $66.6 Mn +$4.5 Mn +51.8%
2032 (forecast) $71.4 Mn +$4.8 Mn +62.7%
2033 (forecast) $76.6 Mn +$5.1 Mn +74.4%
2034 (forecast) $82.1 Mn +$5.5 Mn +87%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $1.69 Bn
  2. North America $783.1 Mn
  3. US $760.0 Mn
  4. APAC $408.8 Mn
  5. Europe $271.4 Mn
  6. China $132.5 Mn
  7. Japan $121.1 Mn
  8. Canada $118.1 Mn
  9. Latin America $77.9 Mn
  10. Germany $67.3 Mn
  11. Middle East $64.2 Mn
  12. UK $42.7 Mn
  13. France $43.2 Mn
  14. Brazil (this report) $43.9 Mn
  15. Italy $34.7 Mn
  16. Ecuador $33.1 Mn
  17. India $31.7 Mn
  18. Spain $29.0 Mn
  19. Saudi Arabia $29.5 Mn
  20. Mexico $27.2 Mn
  21. Africa $25.1 Mn
  22. Australia $22.3 Mn
  23. Russia $19.0 Mn
  24. New Zealand $16.5 Mn
  25. South Africa $11.7 Mn
  26. UAE $9.5 Mn
  27. Egypt $4.4 Mn
  28. Philippines $4.0 Mn
  29. Malaysia $3.1 Mn
  30. Hong Kong $2.5 Mn
  31. Singapore $1.9 Mn
  32. Thailand $1.9 Mn
  33. Kenya $1.2 Mn

Report snapshot

Brazil PTSD Treatment Market Analysis at a glance
Market size, 2025$43.9 Mn placeholder estimate
Forecast, 2034$82.1 Mn placeholder estimate
Growth (CAGR), 2025–20347.2% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
Also calledPost-Traumatic Stress Disorder Treatment
SegmentsTreatment, population and end user (see all)
Key playersPfizer Inc., Viatris, Lykos Therapeutics, Otsuka Pharmaceutical Co., Ltd., Tonix Pharmaceuticals (see all)
Regulator in BrazilANVISASource: ANVISA. Checked 14 Nov 2026.
Active clinical trials1 in BrazilSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Brazil. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Brazil PTSD Treatment Market Analysis Executive Summary

PTSD treatment helps people recover from trauma using therapies, medicines and new approaches such as MDMA-assisted therapy.

Key segments of the PTSD Treatment market include treatment (Psychotherapy, SSRIs and SNRIs and Psychedelic-Assisted Therapy) and population (Veterans and Military and Civilians).

Bar chart: Brazil PTSD Treatment market size, 2024–2034, placeholder estimates. $41.0 Mn in 2024, $43.9 Mn in 2025 and $82.1 Mn in 2034, 7.2% CAGR.
Brazil PTSD Treatment market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Brazil PTSD Treatment Market Dynamics

Market Growth Drivers

More people seeking help for mental health, less stigma, better screening and new treatments with faster effects are driving the PTSD Treatment market. Governments and employers are investing more in mental health care.

Opportunity

Digital tools, new drug classes and care built into primary care and workplaces give the PTSD Treatment market strong room to grow worldwide.

Market Restraints

Shortages of mental health professionals, limited insurance coverage, side effects and the need for long-term treatment hold back the PTSD Treatment market.

Competitive Landscape for PTSD Treatment Market in Brazil

The PTSD Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for PTSD Treatment Market in Brazil

PTSD Treatment in Brazil: rules, payment and research

Medicines need registration with ANVISA, the National Health Surveillance Agency, before sale.⁠[1] The Unified Health System (SUS) gives free public care to everyone, and CONITEC advises which medicines and technologies it adds.⁠[2] ClinicalTrials.gov lists 1 study on PTSD Treatment that is recruiting, active or about to start in Brazil.⁠[3] Suicide rate: 8.8 per 100,000 people in 2023, the latest WHO figure for Brazil.⁠[4]

[1] ANVISA. Checked 14 Nov 2026.

[2] CONITEC. Checked 14 Nov 2026.

[3] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Brazil. Retrieved 12 Nov 2026.

[4] WHO Global Health Observatory, Suicide rate (per 100,000 people). Retrieved 15 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for PTSD Treatment. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Brazil.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in PTSD Treatment right now, from free public sources.

Latest research 660 papers since 2021 (worldwide)

  1. Pharmacotherapeutic strategies for the treatment of the most frequent psychiatric comorbidities in PTSD. Expert opinion on pharmacotherapy, 2026
  2. Engagement and outcomes of veterans endorsing suicidal ideation in a couple-based treatment for posttraumatic stress disorder. Journal of traumatic stress, 2026
  3. The effects of gender on response to prolonged exposure therapy for posttraumatic stress disorder among adults receiving medications for opioid use disorder. Psychological trauma : theory, research, practice and policy, 2026
  4. Adapted Massed Exposure Therapy Enhanced with MDMA for PTSD (aMETEMP): A randomized, double-masked protocol adapted for Veterans Affairs healthcare system. Contemporary clinical trials communications, 2026
  5. Cannabidiol prevents fear extinction deficits caused by single prolonged stress in rats: possible involvement of serotoninergic, cannabinoid, and nitric mechanisms. Neuropharmacology, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

PTSD Treatment in context

Brazil compared

  • Suicide rate: 8.8 per 100,000 people (2023). World: 9.2 per 100,000 people (2023). Highest of the 4 countries we cover in Latin America.[1]
  • Health spending per person: 1,010 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 4 countries we cover in Latin America.[2]
  • Doctors: 2.36 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). 2nd highest of the 4 countries we cover in Latin America.[3]

[1] WHO Global Health Observatory, Suicide rate (per 100,000 people). Retrieved 15 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the PTSD Treatment market in Brazil?
Placeholder estimate: about $43.9 Mn in 2025, rising to about $82.1 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the PTSD Treatment market in Brazil growing?
Placeholder estimate: about 7.2% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the PTSD Treatment market report cover?
The report splits the market by treatment (Psychotherapy, SSRIs and SNRIs, Psychedelic-Assisted Therapy, Digital Therapy), population (Veterans and Military, Civilians) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the PTSD Treatment market?
Key players include Pfizer Inc., Viatris, Lykos Therapeutics, Otsuka Pharmaceutical Co., Ltd. and Tonix Pharmaceuticals.
What is driving the PTSD Treatment market?
More people seeking help for mental health, less stigma, better screening and new treatments with faster effects are driving the PTSD Treatment market. Governments and employers are investing more in mental health care.
Who regulates PTSD Treatment in Brazil?
Medicines need registration with ANVISA, the National Health Surveillance Agency, before sale. Source: ANVISA. Checked 14 Nov 2026.
How is healthcare paid for in Brazil?
The Unified Health System (SUS) gives free public care to everyone, and CONITEC advises which medicines and technologies it adds. Source: CONITEC. Checked 14 Nov 2026.
How many clinical trials on PTSD Treatment are running in Brazil?
1 study is recruiting, active or about to start in Brazil, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Brazil. Retrieved 12 Nov 2026.
What does WHO report for Brazil?
Suicide rate: 8.8 per 100,000 people in 2023, the latest WHO figure. Source: WHO Global Health Observatory, Suicide rate (per 100,000 people). Retrieved 15 Nov 2026.
How many people in Brazil are 65 or older?
11.5% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 15 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about PTSD Treatment in Brazil? Our analysts can size it for your plan. Talk to us See the public data Suicide rate for every country, free. Open the Public Health Dashboard

From our blog

Adaptogens: Ancient Herbs, Modern Market170 WHO Member States report the use of traditional medicine. Adaptogens like ashwagandha, rhodiola and… Stress and Mood Supplements: Ashwagandha and BeyondDepression and anxiety cost the world about US$1 trillion a year. Ashwagandha has some evidence for stress… Antidepressants: Demand, Access and New ApproachesAbout 322 million people live with depression. Treatment works, but most people still do not get it.
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in Brazil

See all
Same topic, other categories

Related on mental health

See the topic